The mechanisms and consequences of ultraviolet-induced immunosuppression in the skin and eye

Eye and Contact Lens

Volumn 37, Issue 4, 2011, Pages 176-184

  Norval, Mary ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Chromophore; Cytokines; Herpetic stromal keratitis; Immunosuppression; Photokeratitis; Pterygium; Skin immune system; T regulatory cells; Ultraviolet

Indexed keywords

ALPHA INTERMEDIN; BCG VACCINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FREE RADICAL; HISTAMINE; IMIQUIMOD; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MEASLES VACCINE; MUMPS VACCINE; NEUROPEPTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLIOMYELITIS VACCINE; REACTIVE OXYGEN METABOLITE; RECOMBINANT HEPATITIS B VACCINE; RUBELLA VACCINE; SEROTONIN RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UROCANATE HYDRATASE; UROCANIC ACID; VITAMIN D;

ALLERGIC REACTION; ANTIBODY RESPONSE; APOPTOSIS; ASTHMA; AUTOIMMUNE DISEASE; BACTERIUM; BASAL CELL CARCINOMA; BCG VACCINATION; CATABOLISM; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CHROMATOPHORE; CORNEA CELL; CORNEA ULCER; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; DERMIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA DAMAGE; DOWN REGULATION; DRUG EFFICACY; DRY EYE; EPIDERMIS; EUROPE; EYE; EYE DISEASE; FUNGUS; GENE CONTROL; GENOTYPE; GRAFT REJECTION; HELPER CELL; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INFECTION; INNATE IMMUNITY; INOCULATION; KERATINOCYTE; KERATITIS; LANGERHANS CELL; LATITUDE; LEISHMANIASIS; LEPROSY; LIPID PEROXIDATION; LONG TERM EXPOSURE; LYMPH NODE; MACROPHAGE; MAST CELL; MEASLES VACCINATION; MELANOMA; MONOCYTE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEMATODE; NEUTROPHIL; NONHUMAN; NORTH AMERICA; OPTIC NERVE; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; PATHOGEN LOAD; PHOTODERMATOSIS; PHOTOKERATITIS; PHOTON; PREVALENCE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTOZOON; PTERYGIUM; RADIATION DOSE; RADIATION EXPOSURE; RECURRENT DISEASE; RECURRENT INFECTION; REGULATORY T LYMPHOCYTE; REVIEW; SEASONAL VARIATION; SKIN; SKIN CANCER; SKIN INFECTION; SKIN INFLAMMATION; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS TISSUE; SUMMER; SUN EXPOSURE; SUNBURN; T LYMPHOCYTE; TH1 CELL; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; UPREGULATION; VIRUS; WINTER;

ANIMALS; EYE; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; SKIN; ULTRAVIOLET RAYS;

EID: 79960008230     PISSN: 15422321     EISSN: 1542233X     Source Type: Journal    
DOI: 10.1097/ICL.0b013e31821d7573     Document Type: Review

References (78)

1. Kripke ML. Antigenicity of murine skin tumours induced by ultraviolet light. J Natl Cancer Inst 1974;53:1333-1336.
2. Kripke ML, Fisher MS. Immunologic parameters of ultraviolet carcinogenesis. J Natl Cancer Inst 1976;57:211-215.
3. Fisher MS, Kripke ML. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc Natl Acad Sci USA 1977;74:1688-1692. (Pubitemid 8087041)
4. Kripke ML. Immunologic mechanisms in UV radiation carcinogenesis. Adv Cancer Res 1981;34:69-106.
5. Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005;571:185-205. (Pubitemid 40313441)
6. Norval M, McLoone P, Lesiak A, et al. The effect of chronic ultraviolet radiation on the human immune system. Photochem Photobiol 2008;84:19-28. (Pubitemid 350265104)
7. Huang XX, Bernerd F, Halliday GM. Ultraviolet A within sunlight induces mutations in the epidermal basal layer of engineered human skin. Am J Pathol 2009;174:1534-1543.
8. Gibbs NK, Tye J, Norval M. Recent advances in urocanic acid photochemistry, photobiology and photoimmunology. Photochem Photobiol Sci 2008;7:655-667. (Pubitemid 351798454)
9. Walterscheid JP, Nghiem DX, Kazimi N, et al. Cis-urocanic acid, a sunlightinduced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc Natl Acad Sci USA 2006;103:17420-17425. (Pubitemid 44788984)
10. Walterscheid JP, Ullrich SE, Ngheim DX. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 2002;195:171-79. (Pubitemid 34461261)
11. Shreedhar V, Giese T, Sung VW, et al. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 1998;160:3783-3789. (Pubitemid 28176081)
12. Byrne SN, Limon-Flores AY, Ullrich SE. Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J Immunol 2008;180:4648-4655.
13. Toichi E, Lu KQ, Swick AR, et al. Skin-infiltrating monocytes/macrophages migrate to draining lymph nodes and produce IL-10 after contact sensitizer exposure to UV-irradiated skin. J Invest Dermatol 2008;128:2705-2715.
14. Schwarz T. 25 years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cells. Photochem Photobiol 2008;84:10-18. (Pubitemid 350265098)
15. Moodycliffe AM, Ngheim D, Clydesdale G, et al. Immune suppression and skin cancer development. Nat Immunol 2000;1:521-525.
16. Gorman S, Tan JW, Thomas JA, et al. Primary defect in UVB-induced systemic immunomodulation does not relate to immature or functionally impaired APCs in regional lymph nodes. J Immunol 2005;174:6677-6685. (Pubitemid 40705629)
17. Hiramoto K, Mashita Y, Katada T, et al. Immunosuppression by ultraviolet B rays via eyes in mice. Arch Dermatol Res 1997;289:709-711. (Pubitemid 28014203)
18. Hiramoto K, Jikumaru M, Yamate Y, et al. Ultraviolet A irradiation of the eye induces immunomodulation of skin and intestine in mice via hypothalomopituitary-adrenal pathways. Arch Dermatol Res 2009;301:239-244.
19. Hiramoto K. Ultraviolet A irradiation of the eye activates a nitric-oxidedependent hypothalamo-pituitary pro-opiomelanocortin pathway and modulates the functions of Langerhans cells. J Dermatol 2009;36:335-345.
20. Epstein S. Studies in abnormal human sensitivity to light. IV. Photoallergic concept of prurigo aestivalis. J Invest Dermatol 1942;5:289-298.
21. Shornagel IJ, Sigurdsson V, Nijhuis EH, et al. Decreased neutrophil skin infiltration after UVB exposure in patients with polymorphous light eruption. J Invest Dermatol 2004;123:202-206. (Pubitemid 38833482)
22. Kolgen W, Van Weelden H, Den Hengst S, et al. CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption. J Invest Dermatol 1999;113:4-10. (Pubitemid 29328151)
23. Janssens AS, Pavel S, Tensen CP, et al. Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption. Exp Dermatol 2009;18:212-217.
24. Mutyambizi K, Berger CL, Edelson RL. The balance between immunity and tolerance: The role of Langerhans cells. Cell Mol Life Sci 2009;66:831-840.
25. Wolf P, Byrne SN, Gruber-Wackernagel A. New insights into the mechanisms of polymorphic light eruption: Resistance to ultraviolet radiation-induced immune suppression as an aetiological factor. Exp Dermatol 2009;18:350-356.
26. Koulu LM, Laihia JK, Peltoniemi HH, et al. UV-induced tolerance to a contact allergen is impaired in polymorphic light eruption. J Invest Dermatol 2010;130:2578-2582.
27. Lembo S, Fallon J, O'Kelly P, et al. Polymorphic light eruption and skin cancer prevalence: Is one protective against the other? Br JDermatol 2008;159:1342-1347.
28. Acheson ED, Bachrach CA. The distribution of multiple sclerosis in U.S. veterans by birth place. Am J Hyg 1960;72:88-99.
29. McLeod JG, Hammond SR, Hallpike JF. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results. Med J Aust 1994;160:117-122. (Pubitemid 2049244)
30. Sloka JS, Pryse-Phillips WE, Stefanelli M. The relation of ultraviolet radiation and multiple sclerosis in Newfoundland. Can J Neurop Sci 2008;35:69-74. (Pubitemid 351518291)
31. Taylor BV, Pearson J, Clarke G, et al. Multiple sclerosis prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler 2010;16: 1422-1431.
32. Staples J, Ponsonby AL, Lim L. Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: Longitudinal analysis. BMJ 2010;340:c1640.
33. van der Mei IA, Ponsonby AL, Dwyer T, et al. Past exposure to sun, skin phototype, and risk of multiple sclerosis: case-control study. BMJ 2003;327:316.
34. McMichael AJ, Hall AJ. Does immunosuppressive ultraviolet radiation explain the latitude gradient for multiple sclerosis? Epidemiology 1997;8: 642-645. (Pubitemid 27449495)
35. Becklund BR, Severson KS, Vang SV, et al. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc Natl Acad Sci USA 2010;107:6418-6423.
36. Gorman S, McGlade JP, Lambert MJ, et al. UV exposure and protection against allergic airways disease. Photochem Photobiol Sci 2010;9:571-577.
37. Ray-Keil L, Chandler JW. Reduction in the incidence of rejection of heterotopic murine corneal transplants by pre-treatment with ultraviolet radiation. Transplantation 1986;42:403-406. (Pubitemid 16005770)
38. Guymer RH, Mandel TE. UV-B irradiation of donor skin and cornea prior to allotransplantation in mice. Transplant Proc 1989;21:3771-3771.
39. Dana MR, Olkowski ST, Ahmadian H, et al. Low-dose ultraviolet-B irradiation of donor corneal endothelium and graft survival. Invest Ophthalmol Vis Sci 1990;31:2261-2268.
40. Hill JC, Sarvan J, Maske R, et al. Evidence that UV-B irradiation decreases corneal Langerhans cells and improves corneal graft in the rabbit. Transplantation 1994;57:1281-1284. (Pubitemid 24139659)
41. Hori J, Isobe M, Yamagami S, et al. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Exp Eye Res 1997;65:89-98.
42. Hamrah P, Haskova Z, Taylor AW, et al. Local treatment with alphamelanocyte stimulating hormone reduces corneal allorejection. Transplantation 2009;88:180-187.
43. Viiri J, Jauhonen HM, Kauppinen A, et al. Cis-urocanic acid suppresses UV-B-induced interleukin-6 and -8 secretion and cytotoxicity in human corneal and conjunctival epithelial cells in vitro. Mol Vis 2009;15:1799-1805.
44. Hartevelt MM, Bouwes-Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49:506-509. (Pubitemid 20110465)
45. Wakita D, Chamoto K, Ohkuri T, et al. IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model. Carcinogenesis 2009;30:1408-1415.
46. Kaporis HG, Guttman-Yassky E, Lowes MA, et al. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. J Invest Dermatol 2007;127:2391-2398. (Pubitemid 47619759)
47. Yoshikawa T, Rae V, Bruins-Slot W, et al. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990;95:530-536.
48. Kelly DA, Young AR, McGregor JM, et al. Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med 2000;191:561-566.
49. Ribatti D, Ennas MG, Vacca A, et al. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 2003;33:420-425. (Pubitemid 36583711)
50. Iamaroon A, Pongsiniwet S, Jittidecharaks S, et al. Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med 2003;32:195-199. (Pubitemid 36604013)
51. Grimbaldeston MA, Finlay-Jones JJ, Hart PH. Mast cells in photodamaged skin: what is their role in skin cancer? Photochem Photobiol Sci 2006;5: 177-183. (Pubitemid 43228045)
52. Barnetson RS, Satchell A, Zhuang L, et al. Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD T cells and dendritic cells. Clin Exp Dermatol 2004;29: 639-643. (Pubitemid 39573657)
53. Beissert S, Ruhlemann D, Mohammad T, et al. IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: Implications for photocarcinogenesis. J Immunol 2001;167:6232-6238. (Pubitemid 33081552)
54. Sreevidya CS, Khaskhely NM, Fukunaga A, et al. Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists. Cancer Res 2008;68:3978-3984.
55. Muller HK, Malley RC, McGee HM, et al. Effect of UV radiation on the neonatal skin immune system-Implications for melanoma. Photochem Photobiol 2008;84:47-54. (Pubitemid 350265107)
56. Halliday KE, Norval M. The effects of ultraviolet radiation on infectious diseases. Rev Med Microbiol 1997;8:179-188. (Pubitemid 27445582)
57. Norval M, Garssen J, van Loveren H, et al. UV-induced changes in the immune response to microbial infections in human subjects and animal models. J Epidemiol 1999;9:s84-s92.
58. Glaser R, Navid F, Schuller W, et al. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol 2009;123:1117-1123.
59. Norval M. The effects of ultraviolet radiation on human viral infections. Photochem Photobiol 2006;86:1495-1504. (Pubitemid 46158838)
60. Damian DL, Halliday GM, Taylor CA, et al. Ultraviolet radiation induced suppression of Mantoux reactions in humans. J Invest Dermatol 1998;110: 824-827. (Pubitemid 28194035)
61. Moyal D, Courbiere C, Le Corre Y, et al. Immunosuppression induced by chronic solar-simulated irradiation in humans and its prevention by sunscreens. Eur J Dermatol 1997;7:223-225. (Pubitemid 27192279)
62. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698-702. (Pubitemid 24061706)
63. John TJ, Jayabal P. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am J Epidemiol 1972;96:263-269.
64. Linder N, Abudi Y, Abdulla W, et al. Effect of season of inoculation on immune response to rubella vaccine in children. J Trop Pediatr [published online ahead of print November 4, 2009]. doi:10.1093/tropej/fmp104.
65. Sleijffers A, Garssen J, de Gruijl FR, et al. Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers. J Invest Dermatol 2001;117:1144-1150. (Pubitemid 34205910)
66. Sleijffers A, Yucesoy B, Kashon M, et al. Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination. J Immunol 2003;170:3423-3428. (Pubitemid 36302222)
67. Sleijffers A, Kammeyer A, de Gruijl FR, et al. Epidermal cis-urocanic acid levels correlate with lower specific cellular immune responses after hepatitis B vaccination of ultraviolet B-exposed humans. Photochem Photobiol 2003; 77:271-275.
68. Stein-Streilein J. Immune regulation and the eye. Trends Immunol 2008;29: 548-554.
69. Forrester N. Privilege revisited: An evaluation of the eye's defence mechanisms. Eye 2009;23:756-766.
70. Taylor AW. Ocular immune privilege. Eye 2009;23:1885-1889.
71. Pauloin T, Dutot M, Joly F, et al. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis 2009;15:577-583.
72. Kennedy M, Kim KH, Harten B, et al. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci 1997;38:2483-2491. (Pubitemid 27492749)
73. Biswas PS, Rouse BT. Early events in HSV keratitis-Setting the stage for a blinding disease. Microbes Infect 2005;7:799-810. (Pubitemid 40720435)
74. Toma HS, Murina AT, Areaux RG, et al. Ocular HSV-1 latency, reactivation and recurrent disease. Semin Ophthalmol 2008;23:249-273. (Pubitemid 351918598)
75. Carr DJ, Austin B, Halford WP, et al. Delivery of interferon-g by an adenovirus blocks herpes simplex virus type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways. J Neuroimmunol 2009;206:39-43.
76. Kreisel JD, Ricigliano J, Spruance SL, et al. Neuronal reactivation of herpes simplex virus may involve interleukin-6. J Neurovirol 1997;3:441-448. (Pubitemid 28041144)
77. Reid TW, Dushku N. What a study of pterygia teaches us about the cornea? Molecular mechanisms of formation. Eye Contact Lens 2010;36:290-295.
78. Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: Trends and perspectives (review).Int J Mol Med 2009;23:439-447.